No abstract available
Keywords:
Biliary cancer; cholangiocarcinoma; immune checkpoints inhibitors; molecular targeted agents; perioperative therapy.
MeSH terms
-
Bile Duct Neoplasms / diagnosis
-
Bile Duct Neoplasms / mortality
-
Bile Duct Neoplasms / therapy*
-
Cholangiocarcinoma / diagnosis
-
Cholangiocarcinoma / mortality
-
Cholangiocarcinoma / therapy*
-
Humans
-
Prognosis